NCT06889363

Brief Summary

The aim of this study is the clinical and radiographic evaluation of (Platelet-Rich Fibrin (PRF) versus Mineral Trioxide Aggregate (MTA) in indirect pulp capping when used with deep carious molars over 1 year follow up.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_2

Timeline
4mo left

Started Jun 2025

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress75%
Jun 2025Sep 2026

First Submitted

Initial submission to the registry

March 17, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 21, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 1, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

March 21, 2025

Status Verified

March 1, 2025

Enrollment Period

1.3 years

First QC Date

March 17, 2025

Last Update Submit

March 17, 2025

Conditions

Keywords

Molar cariesMTAPRFIndirect pulp cappingDeep carious lesioncarious molarsplatelet rich fibrin

Outcome Measures

Primary Outcomes (1)

  • Pulp sensibility using cold test

    clinical finding of the investigated tooth measured with binary (yes or no)

    baseline, 3 , 6, 12 months

Secondary Outcomes (1)

  • Radiographic finding

    baseline, 3 , 6, 12 months

Study Arms (2)

Deep carious molars, indirect pulp capping using PRF then GI base then composite restoration

EXPERIMENTAL

Deep carious molars, indirect pulp capping using PRF then GI base then composite restoration

Biological: PRF

Deep carious molars, indirect pulp capping using MTA then GI base then composite restoration

ACTIVE COMPARATOR

Deep carious molars, indirect pulp capping using MTA then GI base then composite restoration

Drug: MTA

Interventions

MTADRUG

The indirect pulp capping will be applied using MTA using an MTA carrier, then glass ionomer will be applied, then composite restoration above

Also known as: mineral trioxide aggregate
Deep carious molars, indirect pulp capping using MTA then GI base then composite restoration
PRFBIOLOGICAL

The indirect pulp capping will be applied using PRF on a membrane, then glass ionomer will be applied , then composite restoration above

Also known as: platelet rich fibrin
Deep carious molars, indirect pulp capping using PRF then GI base then composite restoration

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • o Patients with asymptomatic deep carious molars.
  • Patients with clinically and radiographically confirmed deep carious lesions that do not exhibit spontaneous pain.
  • Permanent molars only.
  • Teeth with intact or minimally restored occlusal surfaces (i.e., no extensive restorations or fractures).
  • No history of previous endodontic treatment or direct pulp capping on the study tooth.
  • No signs of periapical pathology based on radiographic evaluation.
  • Patients willing to participate and follow up for 12 months.
  • Patients who agree to return for scheduled follow-ups at 3, 6, and 12 months.

You may not qualify if:

  • o Patients with systemic conditions affecting bone or tissue healing (e.g., uncontrolled diabetes, osteoporosis, immunosuppressed conditions).
  • Pregnant or lactating women (if applicable to your study).
  • Teeth with pulp exposure or necrotic pulp.
  • Presence of symptomatic irreversible pulpitis (e.g., spontaneous pain, lingering pain).
  • Periapical pathology or internal/external resorption detected radiographically.
  • Severely broken down or non-restorable teeth.
  • Calcified root canals or excessive sclerosis that could affect pulp testing reliability.
  • Any pre-existing root canal treatment on the selected tooth.
  • Patients who have undergone recent fluoride treatment, pulpotomy, or other pulp therapies in the past 6 months.
  • Patients using medications affecting bone and tissue regeneration (e.g., bisphosphonates, corticosteroids).
  • Patients unwilling or unable to commit to the 12-month follow-up schedule.
  • Patients with poor oral hygiene or high caries risk that could compromise treatment outcomes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Giza, القاهرة - Cairo Governorate, 11585, Egypt

Location

MeSH Terms

Conditions

Dental Caries

Interventions

Pemetrexedmineral trioxide aggregate

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

GuanineHypoxanthinesPurinonesPurinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsGlutamatesAmino Acids, AcidicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, Dicarboxylic

Central Study Contacts

salma mohamed monir, MSc Cairo university

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
statistician
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

March 17, 2025

First Posted

March 21, 2025

Study Start

June 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

March 21, 2025

Record last verified: 2025-03

Locations